Affordable Access

Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage : a randomised controlled trial in Benin and Mali

Authors
  • Dumont, Alexandre
  • Bodin, C.
  • Hounkpatin, B.
  • Popowski, T.
  • Traoré, M.
  • Perrin, R.
  • Rozenberg, P.
Publication Date
Jan 01, 2017
Source
Horizon Pleins textes
Keywords
Language
English
License
Unknown
External links

Abstract

Objective: To assess the effectiveness of low-cost uterine tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage (PPH) in low-resource settings. Design Randomised controlled trial. Setting: Seven healthcare facilities in Cotonou, Benin and Bamako, Mali. Population: Women delivering vaginally who had clinically diagnosed PPH that was suspected to be due to uterine atony, who were unresponsive to oxytocin and who needed additional uterotonics. Methods: Women were randomly assigned to receive uterine balloon tamponade with a condom-catheter device or no tamponade; both groups were also given intrarectal or sublingual misoprostol. Main outcome measure Proportion of women with invasive surgery or who died before hospital discharge. Results: The proportion of primary composite outcome did not differ significantly between the tamponade arm (16%; 9/57) and the standard second line treatment arm (7%; 4/59): relative risk 2.33 (95% CI 0.76 to 7.14, p= 0.238). A significantly increased proportion of women with tamponade and misoprostol versus misoprostol alone had total blood loss more than 1000 mL: relative risk 1.52 (95% CI 1.15 to 2.00, p= 0.01). Case fatality rate was higher in the tamponade group (10%; 6/57) than in the control group (2%; 1/59) (p= 0.059).

Report this publication

Statistics

Seen <100 times